13 studies found for:    GetGoal
Show Display Options
Download search resultsDownload the search results for:
GetGoal (13 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Device: Pen auto-injector
2 Completed GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Device: Pen auto-injector;   Drug: Sulfonylurea;   Drug: Basal Insulin
3 Completed GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Device: Pen auto-injector
4 Recruiting Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
Condition: Type 2 Diabetes
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo
5 Completed GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Device: Pen auto-injector;   Drug: Pioglitazone;   Drug: Metformin
6 Completed GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Drug: Basal Insulin;   Drug: Metformin;   Device: Pen auto-injector
7 Completed GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Device: Pen auto-injector;   Drug: Sulfonylurea;   Drug: Metformin
8 Completed GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Device: Pen auto-injector;   Drug: Exenatide;   Device: Prefilled pen injector;   Drug: Metformin
9 Completed GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Device: Pen auto-injector;   Drug: Metformin
10 Completed 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Drug: Insulin glargine;   Device: Pen auto-injector;   Drug: Metformin;   Drug: Thiazolidinedione (TZD)
11 Completed GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Device: Pen auto-injector;   Drug: Metformin
12 Active, not recruiting Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
Condition: Type 2 Diabetes
Interventions: Drug: lixisenatide (AVE0010);   Drug: insulin glulisine (HMR1964)
13 Completed Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Device: Pen auto-injector;   Drug: Metformin;   Drug: Sulfonylurea

Indicates status has not been verified in more than two years